【结 构 式】 |
【分子编号】41414 【品名】N-[(2S)-3-[((2R,3R,4R,5R,6R)-4,5-bis(acetoxy)-6-[(acetoxy)methyl]-3-[[(3R)-3-(tetradecanoyloxy)tetradecanoyl]amino]tetrahydro-2H-pyran-2-yl)oxy]-2-(tetradecanoylamino)propanoyl]-beta-alanine 【CA登记号】 |
【 分 子 式 】C60H107N3O15 【 分 子 量 】1110.5208 【元素组成】C 64.89% H 9.71% N 3.78% O 21.61% |
与该中间体有关的原料药合成路线共 1 条
合成路线1
该中间体在本合成路线中的序号:(X)Intermediate (VII) was coupled with beta-alanine benzyl ester (VIII) to give amide (IX). After hydrogenolysis of the benzyl ester of (IX), the acetate esters were removed by treatment with ammonia in MeOH, THF.
【1】 Miyajima, K.; Nekado, T.; Ikeda, K.; Achiwa, K.; Synthesis of Tn, sialyl Tn and HIV-1-derived peptide antigen conjugates having a lipid A analog as an immunoadjuvant for synthetic vaccines. Chem Pharm Bull 1998, 46, 11, 1676. |
【2】 Ikeda, K.; et al.; Lipid A and related compounds. XXXVII. Determination of favorable binding linkages of lipid A analog to antigen moiety for synthetic vaccines. Chem Pharm Bull 2000, 48, 1, 32. |
【3】 Miyajima, K.; et al.; Synthesis of TN and sialyl TN antigen-lipid an analog conjugates for synthetic vaccines. Chem Pharm Bull 1997, 45, 9, 1544. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(VII) | 41412 | (2S)-3-[((2R,3R,4R,5R,6R)-4,5-bis(acetoxy)-6-[(acetoxy)methyl]-3-[[(3R)-3-(tetradecanoyloxy)tetradecanoyl]amino]tetrahydro-2H-pyran-2-yl)oxy]-2-(tetradecanoylamino)propionic acid | C57H102N2O14 | 详情 | 详情 | |
(VIII) | 30194 | benzyl 3-aminopropanoate | 27019-47-2 | C10H13NO2 | 详情 | 详情 |
(IX) | 41413 | (1R)-1-[2-[((2R,3R,4R,5R,6R)-4,5-bis(acetoxy)-6-[(acetoxy)methyl]-2-[[(2S)-3-[[3-(benzyloxy)-3-oxopropyl]amino]-3-oxo-2-(tetradecanoylamino)propyl]oxy]tetrahydro-2H-pyran-3-yl)amino]-2-oxoethyl]dodecyl myristate | C67H113N3O15 | 详情 | 详情 | |
(X) | 41414 | N-[(2S)-3-[((2R,3R,4R,5R,6R)-4,5-bis(acetoxy)-6-[(acetoxy)methyl]-3-[[(3R)-3-(tetradecanoyloxy)tetradecanoyl]amino]tetrahydro-2H-pyran-2-yl)oxy]-2-(tetradecanoylamino)propanoyl]-beta-alanine | C60H107N3O15 | 详情 | 详情 |
Extended Information